The early benefit assessment in the context of the Act on the Reform of the Market for Medicinal Products (AMNOG)

A critical analysis from the perspective of the stakeholders at the end of the 17th legislative period

Nonfiction, Health & Well Being, Health
Cover of the book The early benefit assessment in the context of the Act on the Reform of the Market for Medicinal Products (AMNOG) by Sara Schlenkrich, GRIN Verlag
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Sara Schlenkrich ISBN: 9783656766018
Publisher: GRIN Verlag Publication: October 10, 2014
Imprint: GRIN Verlag Language: English
Author: Sara Schlenkrich
ISBN: 9783656766018
Publisher: GRIN Verlag
Publication: October 10, 2014
Imprint: GRIN Verlag
Language: English

Bachelor Thesis from the year 2013 in the subject Health Science, grade: 1,4, Neisse University Görlitz, course: V282129, language: English, abstract: The Act on the Reform of the Market for Medicinal Products, which entered into force on the 1st of January 2011, brought about a fundamental change in the balance of power on the pharmaceutical market. This thesis therefore sets out to answer the following question: What impact does the early benefit assessment in the context of the Act on the Reform of the Market for Medicinal Products have on the stakeholders of the healthcare system? To answer this question, this work first presents the theoretical foundations of the law, of the early benefit assessment and the bodies involved. It then takes stock of the decisions taken to date before describing the impact on the selected stakeholders. The following findings were reached: As the representative of the statutory health insurance funds, the Central Federal Association of Statutory Health Insurance Funds has gained in power and now decides, as a member of the Federal Joint Committee, on the added benefit of a drug and, depending on this decision, also on the future reimbursement rate. Pharmaceutical companies, however, are losing clout and must comply with the guidelines and assessments of the early benefit assessment. Patients stand to gain and lose out from the early benefit assessment. They are the ones who are ultimately dependent on the medicinal product and its improvement and benefit from a proven benefit. However, they have no say in the early benefit assessment procedure.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Bachelor Thesis from the year 2013 in the subject Health Science, grade: 1,4, Neisse University Görlitz, course: V282129, language: English, abstract: The Act on the Reform of the Market for Medicinal Products, which entered into force on the 1st of January 2011, brought about a fundamental change in the balance of power on the pharmaceutical market. This thesis therefore sets out to answer the following question: What impact does the early benefit assessment in the context of the Act on the Reform of the Market for Medicinal Products have on the stakeholders of the healthcare system? To answer this question, this work first presents the theoretical foundations of the law, of the early benefit assessment and the bodies involved. It then takes stock of the decisions taken to date before describing the impact on the selected stakeholders. The following findings were reached: As the representative of the statutory health insurance funds, the Central Federal Association of Statutory Health Insurance Funds has gained in power and now decides, as a member of the Federal Joint Committee, on the added benefit of a drug and, depending on this decision, also on the future reimbursement rate. Pharmaceutical companies, however, are losing clout and must comply with the guidelines and assessments of the early benefit assessment. Patients stand to gain and lose out from the early benefit assessment. They are the ones who are ultimately dependent on the medicinal product and its improvement and benefit from a proven benefit. However, they have no say in the early benefit assessment procedure.

More books from GRIN Verlag

Cover of the book Der Wandel der Pay-TV-Märkte Europas und der Einfluss der EU-Kommission by Sara Schlenkrich
Cover of the book Die bionische Anwendbarkeit des Prinzips der Facettenaugen by Sara Schlenkrich
Cover of the book Bilder in den Köpfen der Kinder erzeugen by Sara Schlenkrich
Cover of the book Neuerungen bei der Gewerbesteuer by Sara Schlenkrich
Cover of the book Formen der Personalisierung im Internet anhand von Praxisbeispielen by Sara Schlenkrich
Cover of the book Frauenportraits bei Plinius dem Jüngeren by Sara Schlenkrich
Cover of the book 'Stadt der Frauen'. Frauen der Stadt by Sara Schlenkrich
Cover of the book Mixen eines Aperitifs - der Negroni (Unterweisung Hotelfachmann / -frau) by Sara Schlenkrich
Cover of the book Theodor W. Adornos Erziehung nach Auschwitz und Erziehung zur Mündigkeit by Sara Schlenkrich
Cover of the book Prevención de la violencia en menores internados por primera vez mediante planificación de actividades en centro de menores by Sara Schlenkrich
Cover of the book Energiesparen in privaten Haushalten by Sara Schlenkrich
Cover of the book Funktionen und Instrumente des Beschaffungscontrollings by Sara Schlenkrich
Cover of the book Spiel- und Übungsformen mit dem Alltagsmaterial Zeitungen by Sara Schlenkrich
Cover of the book Die Familie in der Gesellschaft: Ein Vergleich der Stellung der Familien in Deutschland und Frankreich by Sara Schlenkrich
Cover of the book Die Entwicklung des Heimatkundeunterrichts im Bildungs- und Erziehungskonzept der DDR by Sara Schlenkrich
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy